"INTERPRETATION AND USE OF FRAX® IN CLINICAL PRACTICE": DOES THE OFFICIAL POSITION ANSWER TO OUR CONCERNS?

被引：1

作者：

Poiana, C. ^{[1
,2
]}

机构：

[1] Carol Davila Univ Med & Pharm, Dept Endocrinol, Bucharest 011863, Romania

[2] CI Parhon Inst Endocrinol, Bucharest, Romania

来源：

ACTA ENDOCRINOLOGICA-BUCHAREST | 2011年 / 7卷 / 03期

关键词：

fracture risk assessment tool; osteoporosis diagnosis; intervention threshold; official positions; INTERNATIONAL OSTEOPOROSIS FOUNDATION; RISK-ASSESSMENT; FRACTURE RISK; DENSITOMETRY; SOCIETY; DIAGNOSIS;

D O I：

10.4183/aeb.2011.373

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The International Society for Clinical Densitometry (ISCD) and the International Osteoporosis Foundation (IOF) developed the FRAX (R) Position Development Conference (PDC) in Bucharest, Romania, on November 14, 2010, following a two-day joint meeting of the ISCD and IOF called "Interpretation and Use of FRAX (R) in Clinical Practice", in order to bring answers to the numerous questions raised by the introduction and implementation of FRAX in clinical practice and to enhance the quality and clinical utility of fracture risk assessment (1-3).

引用

页码：373 / 377

页数：5

共 50 条

[1] Interpretation and use of FRAX in clinical practice
J. A. Kanis
D. Hans
C. Cooper
S. Baim
J. P. Bilezikian
N. Binkley
J. A. Cauley
J. E. Compston
B. Dawson-Hughes
G. El-Hajj Fuleihan
H. Johansson
W. D. Leslie
E. M. Lewiecki
M. Luckey
A. Oden
S. E. Papapoulos
C. Poiana
R. Rizzoli
D. A. Wahl
E. V. McCloskey
Osteoporosis International, 2011, 22
[2] Interpretation and use of FRAX in clinical practice
Kanis, J. A.
Hans, D.
Cooper, C.
Baim, S.
Bilezikian, J. P.
Binkley, N.
Cauley, J. A.
Compston, J. E.
Dawson-Hughes, B.
El-Hajj Fuleihan, Ghada
Johansson, H.
Leslie, W. D.
Lewiecki, E. M.
Luckey, M.
Oden, A.
Papapoulos, S. E.
Poiana, C.
Rizzoli, R.
Wahl, D. A.
McCloskey, E. V.
OSTEOPOROSIS INTERNATIONAL, 2011, 22 (09) : 2395 - 2411
[3] DOES OUR CURRENT CLINICAL PRACTICE AGREE WITH THE NATIONAL GUIDANCE FOR TREATMENT INTERVENTION ACCORDING TO FRAX?
Sabir, Y.
Sabir, A.
Crabtree, N.
Whallett, A.
OSTEOPOROSIS INTERNATIONAL, 2010, 21 : S511 - S512
[4] Official Positions for FRAX® Clinical Regarding Glucocorticoids: The Impact of the Use of Glucocorticoids on the Estimate by FRAX® of the 10 Year Risk of Fracture
Leib, Edward S.
Saag, Kenneth G.
Adachi, Jonathan D.
Geusens, Piet P.
Binkley, Neil
McCloskey, Eugene V.
Hans, Didier B.
JOURNAL OF CLINICAL DENSITOMETRY, 2011, 14 (03) : 212 - 219
[5] An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications
Dweik, Raed A.
Boggs, Peter B.
Erzurum, Serpil C.
Irvin, Charles G.
Leigh, Margaret W.
Lundberg, Jon O.
Olin, Anna-Carin
Plummer, Alan L.
Taylor, D. Robin
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (05) : 602 - 615
[6] The Use of Sonography in Pediatrics: The Bioethical Concerns in Clinical and Research Practice
Weikle, Nicole
JOURNAL OF DIAGNOSTIC MEDICAL SONOGRAPHY, 2021, 37 (05) : 510 - 512
[7] Personal analysis of fracture risk factors. Clinical conditions for FRAX® tool use in clinical practice
Leszczynski, Piotr
Dudziec, Ewa
Samborski, Wlodzimierz
PRZEGLAD MENOPAUZALNY, 2012, 11 (04): : 287 - 290
[8] COMPUTER INTERPRETATION OF MMPI - ITS USE IN CLINICAL PRACTICE
FOWLER, RD
MILLER, ML
ARCHIVES OF GENERAL PSYCHIATRY, 1969, 21 (04) : 502 - &
[9] Use and Interpretation of Children's Drawing in Clinical Practice
Mendes, Sandra da Silva
Jorge, Joana C. A. L. E. J. O.
Ribeiro, Maria do Ceu
Tomas, Edite
Temudo, Teresa
ACTA MEDICA PORTUGUESA, 2022,
[10] Galactomannan use in clinical practice: providing free testing is not the full answer
dos Santos, Jeniffer S.
Hermes, Djuli M.
Pasqualotto, Alessandro C.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2018, 22 (01): : 37 - 40

← 1 2 3 4 5 →